486 related articles for article (PubMed ID: 17081915)
1. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
Basch E; Iasonos A; McDonough T; Barz A; Culkin A; Kris MG; Scher HI; Schrag D
Lancet Oncol; 2006 Nov; 7(11):903-9. PubMed ID: 17081915
[TBL] [Abstract][Full Text] [Related]
2. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.
Cirillo M; Venturini M; Ciccarelli L; Coati F; Bortolami O; Verlato G
Ann Oncol; 2009 Dec; 20(12):1929-35. PubMed ID: 19622510
[TBL] [Abstract][Full Text] [Related]
3. Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer.
Montemurro F; Mittica G; Cagnazzo C; Longo V; Berchialla P; Solinas G; Culotta P; Martinello R; Foresto M; Gallizioli S; Calori A; Grasso B; Volpone C; Bertola G; Parola G; Tealdi G; Giuliano PL; Aglietta M; Ballari AM
JAMA Oncol; 2016 Apr; 2(4):445-52. PubMed ID: 26720497
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
Di Maio M; Gallo C; Leighl NB; Piccirillo MC; Daniele G; Nuzzo F; Gridelli C; Gebbia V; Ciardiello F; De Placido S; Ceribelli A; Favaretto AG; de Matteis A; Feld R; Butts C; Bryce J; Signoriello S; Morabito A; Rocco G; Perrone F
J Clin Oncol; 2015 Mar; 33(8):910-5. PubMed ID: 25624439
[TBL] [Abstract][Full Text] [Related]
5. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
Basch E; Jia X; Heller G; Barz A; Sit L; Fruscione M; Appawu M; Iasonos A; Atkinson T; Goldfarb S; Culkin A; Kris MG; Schrag D
J Natl Cancer Inst; 2009 Dec; 101(23):1624-32. PubMed ID: 19920223
[TBL] [Abstract][Full Text] [Related]
6. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Dueck AC; Mendoza TR; Mitchell SA; Reeve BB; Castro KM; Rogak LJ; Atkinson TM; Bennett AV; Denicoff AM; O'Mara AM; Li Y; Clauser SB; Bryant DM; Bearden JD; Gillis TA; Harness JK; Siegel RD; Paul DB; Cleeland CS; Schrag D; Sloan JA; Abernethy AP; Bruner DW; Minasian LM; Basch E;
JAMA Oncol; 2015 Nov; 1(8):1051-9. PubMed ID: 26270597
[TBL] [Abstract][Full Text] [Related]
7. Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
Liu L; Suo T; Shen Y; Geng C; Song Z; Liu F; Wang J; Xie Y; Zhang Y; Tang T; Zhang L; Wang W
Qual Life Res; 2020 Nov; 29(11):3009-3015. PubMed ID: 32564293
[TBL] [Abstract][Full Text] [Related]
8. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.
Basch E; Iasonos A; Barz A; Culkin A; Kris MG; Artz D; Fearn P; Speakman J; Farquhar R; Scher HI; McCabe M; Schrag D
J Clin Oncol; 2007 Dec; 25(34):5374-80. PubMed ID: 18048818
[TBL] [Abstract][Full Text] [Related]
9. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB
Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494
[TBL] [Abstract][Full Text] [Related]
10. Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Bæksted C; Nissen A; Pappot H; Bidstrup PE; Mitchell SA; Basch E; Dalton SO; Johansen C
J Pain Symptom Manage; 2016 Aug; 52(2):292-7. PubMed ID: 27090851
[TBL] [Abstract][Full Text] [Related]
11. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Quinten C; Maringwa J; Gotay CC; Martinelli F; Coens C; Reeve BB; Flechtner H; Greimel E; King M; Osoba D; Cleeland C; Ringash J; Schmucker-Von Koch J; Taphoorn MJ; Weis J; Bottomley A
J Natl Cancer Inst; 2011 Dec; 103(24):1851-8. PubMed ID: 22157640
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.
Basch E; Wood WA; Schrag D; Sima CS; Shaw M; Rogak LJ; Kris MG; Shouery M; Bennett A; Atkinson T; Pietanza MC
Clin Trials; 2016 Jun; 13(3):331-7. PubMed ID: 26542025
[TBL] [Abstract][Full Text] [Related]
14. Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Bennett AV; Dueck AC; Mitchell SA; Mendoza TR; Reeve BB; Atkinson TM; Castro KM; Denicoff A; Rogak LJ; Harness JK; Bearden JD; Bryant D; Siegel RD; Schrag D; Basch E;
Health Qual Life Outcomes; 2016 Feb; 14():24. PubMed ID: 26892667
[TBL] [Abstract][Full Text] [Related]
15. Capturing acute toxicity data during lung radiotherapy by using a patient-reported assessment tool.
Tang B; Giuliani M; Le LW; Higgins J; Bezjak A; Brade A; Cho BC; Sun A; Hope AJ
Clin Lung Cancer; 2013 Mar; 14(2):108-12. PubMed ID: 22885348
[TBL] [Abstract][Full Text] [Related]
16. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Chung AE; Shoenbill K; Mitchell SA; Dueck AC; Schrag D; Bruner DW; Minasian LM; St Germain D; O'Mara AM; Baumgartner P; Rogak LJ; Abernethy AP; Griffin AC; Basch EM
J Am Med Inform Assoc; 2019 Apr; 26(4):276-285. PubMed ID: 30840079
[TBL] [Abstract][Full Text] [Related]
17. Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer.
Christodoulou M; McCloskey P; Stones N; Bayman N; Burt P; Chittalia A; Harris M; Lee L; Pemberton L; Sheikh H; Swindell R; Faivre-Finn C
Radiother Oncol; 2014 Aug; 112(2):244-9. PubMed ID: 25107555
[TBL] [Abstract][Full Text] [Related]
18. Is there room for improvement in adverse event reporting in the era of targeted therapies?
Edgerly M; Fojo T
J Natl Cancer Inst; 2008 Feb; 100(4):240-2. PubMed ID: 18270340
[TBL] [Abstract][Full Text] [Related]
19. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Bruner DW; Hanisch LJ; Reeve BB; Trotti AM; Schrag D; Sit L; Mendoza TR; Minasian L; O'Mara A; Denicoff AM; Rowland JH; Montello M; Geoghegan C; Abernethy AP; Clauser SB; Castro K; Mitchell SA; Burke L; Trentacosti AM; Basch EM
Transl Behav Med; 2011 Mar; 1(1):110-22. PubMed ID: 24073038
[TBL] [Abstract][Full Text] [Related]
20. Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting.
Atkinson TM; Rogak LJ; Heon N; Ryan SJ; Shaw M; Stark LP; Bennett AV; Basch E; Li Y
J Cancer Res Clin Oncol; 2017 Apr; 143(4):735-743. PubMed ID: 28093637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]